The New Eugenics: Biohacking, Fertility Startups, and the Future of Choice
By Daniel Hildebrand,
The Humanist
| 10. 01. 2025
From Empowerment to Exclusion
When most people hear the word eugenics, they think of dusty history textbooks and black-and-white photographs: forced sterilizations in the early 20th century, pseudoscientific charts measuring skulls, the language of “fitness” used to justify violence and exclusion. It feels like something safely locked in the past, an embarrassment we’ve collectively outgrown.
But I’ve come to wonder whether eugenics is really gone, or whether it has simply learned to rebrand itself. Instead of state-mandated sterilizations, we now have fertility startups promising “freedom” through egg freezing and embryo selection. Instead of crude racial hierarchies drawn by hand, we have sleek apps offering to optimize the “best traits” for future children. Instead of white-coated doctors backed by governments, we have DIY biohackers in Silicon Valley garages wielding CRISPR kits like toys, a reality underscored by widely available home gene-editing kits like those once sold by The Odin – a biotech company that markets CRISPR tools to hobbyists for as little as $150.
The vocabulary has shifted from “fitness” to “choice,” from “purity” to “optimization,” but the underlying logic feels hauntingly familiar: some lives...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Lizzy Lawrence, Stat News | 10.14.2025